Helen Torley sold $3.4M of Halozyme Therapeutics, Inc. (HALO) stock

Helen Torley, President And CEO of Halozyme Therapeutics, Inc. (HALO), sold 50,000 shares of HALO stock worth $3.4M, per an SEC Form 4 filed May 13, 2026.

The sale was pre-arranged (a 10b5-1 plan or an option exercise), not a fresh decision.

The trade happened on May 11, 2026, 2 days before it was made public.

HALO has moved +67.8% since the trade date, from $66.41 to $111.45 (Sep 21, 2026 close).